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1. Introduction 
Liver transplantation (LT) is an established therapy for end-stage liver disease based on a 
substantial progress in surgical and immunological management of concomitant post- 
transplant phenomena. Apart from rejection and HCV-recurrence, the development of 
biliary strictures is one of the most serious complications observed after LT significantly 
affecting graft and patient survival [1, 2]. Frequently compared to Achilles foot, the 
dynamics of post-transplant biliary restitution may determine the overall transplant success 
and play the role of a critical step after LT. Post-transplant complications in the biliary 
system occur in 10-50% with significant mortality in up to 19% and re-transplantation rates 
of 6-12.5% [3-6]. Early post-transplant biliary complications are predominantly related to 
technical aspects of the operation regarding the insufficiency of bile duct anastomosis, 
biliary leaks or anastomotic stenosis [7]. One third of all biliary complications occur later 
than first two months after LT affecting intrahepatic integrity on donor side and 
functionality of distal parts of the biliary tree in the recipient including the bile duct 
anastomosis and the ampulla of Vater [1, 2, 8]. In contrast to the anastomotic strictures, 
which can be successfully treated endoscopically or surgically, non-anastomotic strictures 
represent a significant therapeutic problem [9, 10]. Non-anastomotic strictures of the bile 
duct may develop in up to 20% of all LTs. Untreated stricture-associated complications may 
lead to cholestasis, severe graft dysfunction, cholangiosepsis, secondary cirrhosis and even 
death [6, 8, 11, 12]. Non-anastomotic strictures may be classified according to their etiology 
into strictures related to PSC-recurrence (primary sclerosing cholangitis), strictures 
occurring due to vascular complications in case of a manifest hepatic artery thrombosis as 
ischemic biliary lesions (IBL), strictures occurring after prolonged ischemia (e.g. successfully 
treated hepatic artery thrombosis) and strictures occurring without an obvious vascular 
complication. In the presence of a macroscopically obviously undisturbed perfusion they are 
described as so-called ischemic type biliary lesions (ITBL). The occurrence of biliary lesions 
after primarily successful LT justifies the necessity to introduce ITBL as an independent 
pathologic entity. In spite of a certain descriptive inaccuracy, the terms “non-anastomotic 
strictures”, “intrahepatic biliary strictures” and “ischemic type biliary strictures” are usually 
used as synonyms for post- transplant strictures, diffuse dilatations and segmental ectasia of 
the biliary tract as a result of inflammation and fibrotic remodeling (figs. 1 and 2) [13]. Due 
to terminological diversity, the incidence of ITBL significantly varies among published 
studies between 1.4 and 26% [1, 5, 14]. The diagnosis “ITBL” may be made only after  
the exclusion of vascular (IBL) and immunologic pathologies (PSC-recurrence and chronic  
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ductopenic rejection) [1]. As a diagnosis of exclusion, ITBL is regarded as a serious 
transplant complication and a notable graft disease, undeniably deserving scientific 
attention. 
1.1 Anatomical aspects of the biliary tract 
Biliary tract is a complex network of ductal structures beginning with Hering-canals, 
merging into major ducts and finally into intestine in a highly coordinated manner [15, 16]. 
Apart from conductive functions, the biliary epithelium demonstrates morphological 
heterogeneity, which depends upon functional requirements [17]. The ability to undergo 
phenotypic changes, to participate in inflammatory processes and even to behave as liver 
progenitor cells underlines the uniqueness of cholangiocytes under physiological conditions 
[15, 18]. In contrast to parenchymal blood supply of liver sinusoids via portal vein and 
hepatic artery, biliary tree predominantly depends on the integrity of the hepatic artery and 
periductal plexus being more vulnerable to transplant-related disrupted blood supply and 
immunologic processes justifying the metaphoric comparison to Achilles foot [19, 20]. 
1.2 Biliary tract reconstruction 
One of the most important surgical steps and goals during LT is the reconstruction of the 
biliary tract and the restitution of its function. The most widely employed reconstructive 
techniques are choledocho-choledochostomy (with or without T-tube) performed in patients 
with uncomplicated anatomy and intact distal segment of the biliary tract including 
functioning sphincter Oddi and Roux-en-Y hepatico-jejunostomy, which is usually reserved 
for cases with intrinsic damage to the biliary system (e.g. PSC) and technically difficult 
anastomosis (e.g. re-transplantation, living donor LT) [6, 21, 22]. Underlying liver disease, 
size of biliary tracts of the donor and the recipient, anatomic aspects, prior surgery on the 
biliary duct and surgeon preference may influence the choice of the reconstructive technique 
[23]. 
2. Non-anastomotic strictures: Morphology 
Chronic disturbance of bile flow, accompanied by inflammatory processes, may lead to the 
development of irregular strictures, dilatations and sequestrations of the biliary tree (figs 1 
and 2). Bacterial ascension, causing cholangitis, cholangiohepatitis and cholangiosepsis, may 
forward the progression of ITBL. Macroscopically, ITBL is classified according to the 
localization of pathological alterations in three groups (type-I: extrahepatic; type-II: 
intrahepatic; type-III: intra- and extrahepatic), which may determine the severity of the 
disease, its course and therapeutic options. Inflammation and remodeling represent the 
functional backbone of ITBL-development. Presence of intracellular cholestasis, abundance 
of lymphocytes and granulocytes and proliferation of new bile ducts represent the 
microscopic picture of ITBL, hardly differing from biliary pathologies with unrelated 
etiologies [24]. Remodeling processes result in the formation of connective tissue. Degree, 
localization and duration of inflammation determine the extent of the disease. Resulting in a 
“scar” and the perpetuation of bile flow obstruction, inflammation and progression of 
biliary damage may promote secondary alterations and forward extensive fibrogenesis and 
tissue remodelling of the graft parenchyma [25]. Finally, graft atrophy and the reduction of 
functional reserve may develop, compromising the result of an initially successful LT. 
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Fig. 1. Cholangiograph. Illustration of central stenosis at the level of distal right and left 
ductus hepatici, diffuse biliary strictures and dilatations in the left lobe, cholestasis in the 
right lobe. ITBL developed within the first post-transplant year 
  
                                           (A)                                                                                     (B) 
Fig. 2. (A) Resected graft with ITBL (left liver lobe). Macroscopically evident atrophy of liver 
parenchyma with broad peribiliary shroud of connective tissue (B) Microscopic view of the 
same graft depicting a profound periductular inflammation (lymphocytes, granulocytes), 
connective tissue and remaining islets of liver parenchyma 
Significant morphological similarities are observed in a non-transplant setting as well: in 
patients with HIV-associated cholangiopathy as vanishing bile duct-syndrome, sclerosing 
cholangitis and shock-liver [1, 26]. In summary, chronic inflammation caused by any 
noxious effectors may lead to the uniform picture described above. Frequently, significant 
difficulties arise in the attempt of differentiation between recurrent PSC and ITBL in the 
graft. Morphologically these entities may present identical pictures [1]. 
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Age (years) older than 60 
Size small-for-size 
Donor  
LT-mode living donor 
Stage of liver disease Child & Pugh C > A or B 
Solution UW > HTK 
retrograde caval Perfusion mode 
gravity arterial perfusion 
Periductal tissue little 
Surgery 
Reconstructive technique hepatico-jejunostomy 
Cold and warm ischemia prolonged 
Reperfusion injury not assessable 
Periductal plexus altered 
Ischemic factors 
Re-arterialization present 
External bile drainge no T-tube Cholangial pressure 
& bile toxicitiy 
Bile acids high bile-to-
phospholipid ratio 
ABO-system incompatible 
Immunosuppression Low level 
Rejection chronic / ductopenic 
Autoimmune disease PSC, PBC, AIH 
Co-infection CMV 
Immunologic factors 
Genetic variants CCRdelta32, Mdr-2 
Table 1. Suspected risk factors for the development of ITBL 
3. Pathophysiology 
The process of ITBL-development is not clearly understood yet. ITBL seems to be a 
polygenic disease, influenced by a whole variety of confounders. Currently identified risk 
factors may be divided into four major pathogenetic columns: peri-operative ischemia 
(including preserving solution), immunologic damage, toxicity of bile salts and 
www.intechopen.com
 Ischemic Type Biliary Lesions 
 
229 
epidemiological confounders [1, 27]. The degree and relation of the functional impact 
among risk factors are not fully investigated. Hereby, ischemic injury seems to be the most 
important factor including cold and warm ischemia during transplantation, disturbed blood 
flow in the peribiliary plexus resulting from an inappropriate procurement of the donor 
liver with little periductal tissue, and hypoxemia during the postoperative period [12, 27]. 
Immunological injury including ABO-incompatibility, rejection, pre-existing liver disease 
with autoimmune component, CMV-Infection, immunosuppressive medication and chronic 
rejection also seem to play a role in the development of the non-anastomotic strictures [1, 27, 
28]. Moreover, bile fluid has been shown to be toxic for the vulnerable biliary epithelium of 
the graft [29]. Although biliary strictures have been reported to be more frequent in 
transplant patients with hepatico-jejunostomy, they may occur, disregarding the type of 
biliary tract reconstruction [6, 30]. Finally, factors related to epidemiology (older donor age, 
advanced stage of pre-transplant liver disease) and donation (preservation solution, 
perfusion technique) also seem to be relevant in the pathogenesis of ITBL [1, 27, 31]. Table 1 
summarizes currently known risk factors. 
4. Diagnostics 
The diagnosis of non-anastomotic lesions or ITBL is made by clinical presentation, exclusion 
of evident vascular complications, histological pattern and cholangiography as gold 
standard either by ERC (endoscopic retrograde cholangiography) or by PTC (percutaneous 
transhepatic cholangiography) [1, 2, 32]. Increased expertise in diagnostic and therapeutic 
ERC in transplant-related liver diseases has been demonstrated to be a safe and effective 
tool. Therefore ERC has been suggested to be the primary method for diagnosis and 
treatment of most transplant-related biliary complications except for acute surgical 
complications (broad insufficiency of biliary duct anastomosis) [33]. The diagnosis “ITBL” is 
made when typical signs of segmental strictures and dilatations appear on the 
cholangiography (fig. 1, 3, 4). 
4.1 Clinical aspects 
Characteristic and disease-specific aspects of clinical presentation do not exist. Symptoms 
reflect cholestasis and subsequent infective tendency ranging from unspecific discomfort in 
the right abdomen, elevated temperatures, shivering and jaundice. Clinical presentation of 
ITBL-patients may cover the whole range of complaints and symptoms originating from the 
biliary tract. Classical symptoms are pruritus, jaundice and fever. Untreated ITBL may lead 
to cholangiosepsis, graft insufficiency and patient death [27]. Clinically, ITBL closely 
resembles liver diseases with chronic inflammation of the biliary tract (PSC, SSC, 
cholangitis) [1]. 
4.2 Laboratory 
Although laboratory parameters are frequently normal or only slightly elevated, alkaline 
phosphatase (AP), gamma glutamyltransferase (γ-GT) and bilirubin may indicate 
pathological processes in the biliary tree. Biochemical results do not reliably reflect early 
stages of the disease and easily be misinterpreted as normal or acceptable in the post- 
transplant setting. Highly sensitive but not disease-specific, laboratory parameters are, 
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nevertheless, helpful as a non-invasive tool and their deviation is frequently the first sign 
perceived in the outpatient setting of most follow-up programs. Cholestatic profile with 
leukocytosis usually indicates complicated biliary pathology. Clinical symptoms and 
pathological laboratory findings may necessitate hospitalization and the initiation of further 
diagnostic procedures [32]. 
  
                                       (A)                                                                                         (B) 
Fig. 3. (A) Cholangiograph (ERC): Illustration of central stenosis at the level of distal right 
and left ductus hepatici, diffuse biliary strictures and dilatations in the left lobe and 
cholestasis in the right lobe. (B) Cholangiograph (ERC): Diffuse strictures and dilatations 
nearly in the entire biliary tree 
  
                                         (A)                                                                                         (B) 
Fig. 4. (A) Cholangiograph (ERC): Central stenosis and proximal cholestasis in both graft 
lobes (B) Cholangiograph (ERC): Relevant strictures close to the biliary bifurcation with 
dilatations in both graft lobes 
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Radiological examination is the most important column in ITBL-diagnostics comprising 
conventional X-ray performed during ERC or PTC and indirect imaging methods: 
ultrasound, computer tomography (CT) and magnetic resonance cholangiography (MRC). 
4.3.1 Ultrasound 
As a safe and easily accessible tool, ultrasound examination including Doppler-mode is 
definitely helpful and routinely performed to rule out vascular causes for biliary 
dysfunction. In contrast to early changes, advanced stages of ITBL may well be assessed by 
ultrasound, revealing dilatations, stenosis and sediment, which predispose to the 
development of secondary complications regarding infection and disease progression. 
However, morphologic differences between naive liver and graft must be considered. Due 
to a higher stiffness of the graft, dilatations caused by strictures tend to appear more slowly 
and less distinctly in the affected biliary tract and may remain invisible or mistaken for 
normal conditions on a routine ultrasound examination. 
4.3.2 Conventional cholangiography 
Cholangiography is usually performed by ERC as the method of choice, if technically 
possible in the absence of contra-indications [9, 32]. Based on the classical endoscopic 
examination of the upper digestive tract, the goal of ERC is the visualization of the biliary 
tract by a selective instillation of contrast agent through the sphincter Oddi (fig. 3, 4). As a 
rather invasive diagnostic method, ERC should be performed with maximal accuracy, in 
order to avoid frequently observed pancreatitis, which is a potentially severe iatrogenic 
complication [34]. In contrast to the usually easily assessable biliary tract, if reconstructed as 
standard choledochocholedochostomy, endoscopic cholangiography is impossible with the 
majority of patients with hepatico-jejunostomy [32]. Occasionally, ERC may be feasible in 
patients with short efferent loops of hepatico-jejunal anastomosis if examined by 
experienced endoscopists. In most cases, cholangiography must be performed 
percutaneously as transhepatic punction and instillation of contrast fluid in the biliary 
system (fig. 6) [2, 35]. Elevated pressure and subsequent dilatation of the biliary tract may 
facilitate the examination. In spite of high effectiveness, transhepatic punction may cause 
graft damage, bleeding and injury of adjacent abdominal organs. Therefore, maximal 
accuracy and caution are required when applying this method. Simultaneous diagnostic and 
therapeutical options are the major advantages of conventional cholangiography (ERC or 
PTC). 
4.3.3 Computer tomography (CT) 
CT-scan may accurately visualize graft perfusion using contrast agent and biliary pathology 
regarding the localization, structural changes and secondary complications (abscess, 
atrophy). In spite of frequent incapability to detect short segment stenosis without pre 
stenotic dilatations, full-blown ITBL can easily be diagnosed by this method [32, 36]. In 
general, CT is considered to be a reliable diagnostic tool. 
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4.3.4 Magnetic resonance cholangiography (MRC) 
MRC is a reliable noninvasive technique to visualize the biliary anastomosis and depict 
biliary strictures after LT (fig. 5) [37]. MR-cholangiography has been shown to be an 
accurate imaging technique to non-invasively detect biliary complications in patients 
especially in patients with bilio-enteric anastomosis with high positive and negative 
predictive values [32, 38]. However, no direct therapeutical options are available during this 
procedure. Non-invasiveness and significant risk reduction for side events are major 
advantages of MRC. Further progress in MRC-processing may increase the potential to 
complement or even replace conventional cholangiographic methods [32]. 
  
                                           (A)                                                                                        (B) 
Fig. 5. (A) Cholangiograph (MRC): Central strictures and proximal diffuse dilatation (B) 
Cholangiograph (MRC): Diffuse strictures and dilatations of the entire biliary tract 
5. Therapy 
Early identification of high risk patients for ITBL-occurrence may help to initiate necessary 
therapeutical steps and possibly prevent disease progression. The goal of ITBL-treatment 
implies the reduction of morbidity and mortality among the diseased transplant population. 
Previously, surgery including re-transplantation of the diseased liver had been thought to 
be the leading therapeutical option for ITBL-patients [39]. Modern ITBL-treatment strategy 
comprises a multimodal approach and an excellent cooperation between departments of 
radiology, endoscopy and surgery (fig. 6) [2, 10, 25]. In most cases the treatment of strictures 
is performed conservatively by endoscopic or transhepatic dilatation [24, 33, 40]. Supportive 
measures should comprise antibiotic prophylaxis and treatment with ursodesoxycholic  
acid [2]. 
5.1 Endoscopic and transhepatic treatment 
Most of the ITBL-patients are currently treated by the endoscopic or percutaneous 
placement of stents and balloon dilatation [32, 33, 40]. However, significantly different 
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success rates are observed depending upon the localization and occurrence of the strictures. 
Anastomotic strictures are usually easier to treat than intrahepatic lesions. Early non-
anastomotic strictures demonstrate higher success rates than strictures appearing later than 
three months after LT [41-43]. Endoscopic and transhepatic treatment options are limited in 
patients with impaired liver function similarly to the diagnostic procedure. Complication 
rates (bleeding, pancreatitis) are reported to be 3.4% for PTC and up to 7% for endoscopic 
treatment [44]. 
5.2 Surgery 
Surgical intervention may still be required in patients who do not respond to dilatative 
treatment or in patients with circumscribed localization of the strictures either in the 
extrahepatic biliary tree or resectable graft lobe [2, 33, 39]. Endoscopic or radiological 
dilatation of strictures has been shown to be ineffective in some patients, who may profit 
from surgical treatment [10]. Therefore, reconstructive surgical approach should be reserved 
to ITBL patients not responsive to endoscopic or trans-hepatic interventions [2]. 
5.2.1 Resection 
Sufficient evidence exists about beneficial effects of partial graft resection, resection of 
biliary bifurcation and performance of hepatico-jejunostomy in liver transplant recipients 
with anatomically limited biliary damage, thus avoiding re-transplantation and preserving 
scarce donor organs [25, 45, 46]. In spite of higher vulnerability of the graft and a certain 
reluctance, graft resection in ITBL-patients with a sufficient graft function is possible and 
comparable to common liver surgery. 
5.2.2 Re-transplantation 
In spite of encouraging progress in interventional non-surgical ITBL-treatment, and 
achievements in graft resection, up to 50% of patients with non-anastomotic strictures still 
require re-transplantation of the liver [30, 43, 47, 48]. Re-transplantation of the liver is 
supposed to be the definitive therapy of graft damage being the last resort of therapeutical 
options. Unfortunately, survival rates after re-transplantation are significantly lower than 
after first LT. In technically more complicated re-transplant setting, cold ischemia and 
MELD-score have been shown to be associated with higher mortality rates [49]. Prevention 
of re-transplantation should be aspired as the goal of ITBL-treatment, especially in the era of 
organ shortage. 
In summary, ITBL-treatment may require an unpredictable amount of patience regarding 
the strategy, performance and follow-up. Exemplarily, more than two dozens of dilatative 
interventions and one graft resection (left hemihepatectomy) have been reported in one case 
of successful ITBL-treatment, preventing re-transplantation of the liver (fig. 6) [25]. 
6. Prevention 
The principle of ITBL-prevention focuses on the major pathogenic factors mentioned above 
and should be considered in the peri-operative period as far as possible. Hereby, allocation, 
preservation, reduction of ischemia, reconstructive techniques and adequate 
immunosuppression seem to be very important. Once, immunological effects were claimed 
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to cause spasms in hepatic arteries, resulting in hypoxemia of the bile duct system [50]. 
Currently, the mechanism of the disease is considered to be multifactorial. Immunological 
injury including ABO-incompatibility, rejection, pre-existing disease with autoimmune 
component, CMV-Infection and chronic rejection also seem to play a role in the 
development of the non-anastomotic strictures [12, 47]. Finally the toxicity of the bile fluid 
has been shown to be relevant in the pathogenesis of ITBL [51]. In summary, the 
development of ITBL is influenced by a whole range of donor, recipient, technical and 
immunological factors. 
     
                           (A)                                                        (B)                                                         (C) 
Fig. 6. (A) ERC after left hemihepatectomy in a patient with ITBL after LT for HCV-induced 
cirrhosis demonstrating a significant stenosis of the right hepatic duct and proximal dilatations 
(B) PTC via Yamakawa-drain of the same patient during the dilatative treatment (C) ERC 
after the completion of treatment depicting acceptable conditions in the right biliary tree 
6.1 Ischemic time 
Several studies have demonstrated a significant correlation of ITBL-incidence with ischemic 
time before reperfusion. In spite of controversial discussion, cold ischemic time especially of 
more than 10 hours may affect the development of ITBL [1, 12, 52]. Analogously, re 
oxigenation and warm ischemia time also seem to be involved in the pathogenesis of the 
disease [27, 53]. Moreover, delayed re-arterialization of the graft may favor the occurrence of 
ITBL [2, 43, 54]. Therefore, the time period between explantation and reperfusion should be 
as short as possible under an adequate preserving temperature. 
6.2 Epidemiologic aspects 
The use of donor organs particularly older than 60 years is associated with ITBL [1, 31]. 
Furthermore, patients with advanced liver disease before transplantation seem to be more 
likely to develop ITBL compared to lower Child and Pugh-stages [1]. Deteriorated pre- 
operative status, early biliary complications and “small-for-size” transplantation are 
currently suspected to contribute to the occurrence and progression of ITBL [55]. Further 
potential confounders regarding the recipient (age, gender) do not seem to play a significant 
role in the pathogenesis of ITBL [1]. Interestingly, the incidence of ITBL seems to be higher 
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in patients undergoing living-donor-liver-transplantation of the right lobe [14, 56]. A 
differentiated selection of donor and recipient simply based on epidemiological data might 
help to avoid the accumulation of predisposing factors. 
6.3 Reconstructive technique 
In spite of ischemia reduction in LDLT-recipients, the increased susceptibility may be 
explained by the difference of biliary reconstruction, which is performed as hepatico- 
jejunostomy compared choledocho-choledochostomy in patients receiving whole organs. 
Bacterial ascension leading to cholangitis may negate the expected advantage of reduced 
cold ischemia time [55, 57]. Thus, the main advantages of choledocho-choledochostomy 
comprise the integrity of anatomic barrier regarding the reflux of intestinal flora to a great 
extent, better technical feasibility than Roux-en-Y and physiological condition for an 
endoscopic access [35, 58]. Choledocho-choledochostomy in side-to-side-technique seems to 
be the most reliable reconstructive method [22, 59]. Particular attention should be paid to 
periductal tissue. The integrity of the periductal vascular plexus must be guaranteed. 
6.4 Preservation and perfusion 
Among the two commonly used preservation solutions, the UW-solution (University of 
Wisconsin) has been shown to increase the risk of ITBL-occurrence compared to the less 
viscous HTK-solution [1, 60, 61]. Furthermore, retrograde graft perfusion via vena cava 
seems to exhibit a negative effect on the development of ITBL, whereas, additional back-
table arterial graft perfusion lowers the risk of ITBL [1, 62]. Regular gravity arterial 
perfusion has been suspected to be insufficient to flush the arterial system of the biliary tract 
completely [1]. All inflammatory active and potential fibrogenic blood compounds should 
be removed before transplantation. Therefore, additional arterial pressure perfusion 
preferably with a HTK-solution should be performed [1]. 
6.5 Toxicity of the bile 
Bile acids may exhibit their toxic potential on vulnerable cholangiocellular epithelium and 
therefore, be relevant in the pathogenesis of ITBL. In contrast to hydrophilic bile salts, 
hydrophobic compounds are cytotoxic [29, 63]. Prolonged warm ischemia is associated with 
the formation of an unfavorable bile salt-to-phospholipid ratio subsequently contributing to 
bile duct injury [51]. The exposure of biliary epithelium to toxic bile compounds can be 
minimized by the careful retrograde flushing of the bile duct with perfusion solution during 
liver explantation, strictly avoiding bile duct ligation [27]. 
6.6 Genetic aspects 
Highly variable rates of functional impairment suggest the existence of endogenous risk 
compounds both in natural and post-transplant settings of the disease. The maximal 
capacity to produce different levels of cytokines in response to noxious stimulation has been 
shown to be under genetic control and differs among liver graft recipients. Chemokine 
receptor 5delta32 polymorphism has been suggested to increase the incidence of ITBL and to 
reduce patient survival [64]. As demonstrated in a rat model, genetic polymorphisms of the 
multidrug resistance protein 2 (Mdr-2), which is involved in the regulative processes of bile  
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fluid composition, may negatively affect bile salt to phospholipid ratio, and contribute to 
cholangiocellular vulnerability [27]. Although, the exact mechanism is not yet understood in 
detail, both, donor and recipient genetics may interact. The expression of disease-related 
effectors may be individual and tissue dependant [65]. In spite of the pathogenetic 
heterogeneity, the role of genetic variants in the development of ITBL should be 
investigated in large scale multi-center trials regarding diagnostic, therapeutic and 
predictive values. Currently, no conclusion can be made considering ITBL-management. 
6.7 External bile drainage 
Internal or external drainage of the bile in the early postoperative period may have an 
impact on the development of non-anastomotic strictures [34]. Although the external bile 
drainage via T-tube is currently a subject of controversy, T-tube insertion has been 
demonstrated to reduce the risk for ITBL in several randomized studies and recent a meta- 
analysis [23, 34, 66-69]. T-tube may prevent the occurrence of ITBL and potentially reduces 
long-term morbidity especially regarding late strictures [34, 67]. The arterial perfusion of the 
biliary tract, which is at risk in transplant setting, remains one of the most important 
determinants of ITBL. Manipulations on ligamentum hepatoduodenale may affect the 
function of sphincter Oddi and result in discoordinated motility of the biliary tract. [6, 33]. 
Sphincter spasms may contribute to bile flow obstruction as demonstrated by elevated intra-
biliary pressure after LT, which has been observed to be twice as high (up to 20mm H2O) as 
in livers without dyskinesia of the biliary tract (10mm H2O) (unpublished data). Elevated 
intra-biliary pressure may aggravate blood supply, which is predominantly maintained by 
periductal arterial plexus [20, 70]. Any kind of tools, which are capable of pressure reduction 
(intra-operative insertion of T-tube, pre-transplant sphincterotomy) should be regarded as 
helpful methods for ITBL-prevention. Moreover, T-tube has been demonstrated to prevent 
bile leakage in split-liver transplantation via pressure reduction [71]. Therefore, T-tube 
should be used in biliary tract reconstruction as side-to-side choledocho-choledochostomy 
during LT, in order to avoid the negative effect of elevated pressure and theoretically 
increased toxic impact of bile acids [59, 66]. 
6.8 Immunological aspects 
Although a rejection is likely to induce significant damage in the biliary tree, no clear 
evidence is currently available about the role in the development of ITBL except for chronic 
ductopenic rejection [1, 2]. Compared to sinusoidal liver parenchyma, cholangiocytes are 
more vulnerable and seem to have less potential for regeneration [15]. Triggered by 
insufficient immunosuppression, immune complexes may induce inflammatory and fibrotic 
processes in tiny arteries of the biliary tract, thus forwarding ischemic damage [47, 72, 73]. 
Unfortunately, only inconsistent data are currently present regarding the role of 
immunosuppression mode and CMV-infection in the development of ITBL [1, 2]. Therefore, 
these factors should be re-evaluated in larger cohorts based on multi-center concepts. In 
contrast to patients transplanted due to virally or metabolically induced liver disease, the 
immunosuppression in patients with autoimmune component should be sufficient and 
preferably stronger according to current standards, in order to prevent rejection processes. 
ABO-incompatibility should be completely avoided because the antigens of the blood-type 
system may also be expressed on biliary epithelium and serve as immunologic target for 
preformed blood group antibodies. 
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7. Conclusion and future prospective 
The development of non-anastomotic strictures in the biliary tract after LT is a serious post-
transplant complication, potentially compromising the initial success of the surgical 
treatment of patients with advanced liver disease. ITBL represents a post-transplant biliary 
disease, which cannot be explained by vascular damage or PSC-recurrence. Due to a strong 
similarity to ischemia-induced biliary injury, and ischemia-reperfusion injury, disrupted or 
disturbed microcirculation seems to be the main pathogenic column. Most probably, ITBL 
develops in a highly individual manner from ischemic injury acquired in the peri-operative 
period predominantly before LT in spite of the restored arterial blood supply. The integrity 
of arterial perfusion separates ischemia-related strictures from IBL, playing a central role in 
the definition of the disease. In spite of the significant correlation between ITBL-incidence 
and pre-transplant ischemia, current definition of ITBL, based on radiological evidence of an 
undisturbed graft perfusion, does not depict the actual extent of ischemic damage. The 
assessment of ischemia- and reperfusion-related alterations should be therefore performed 
at the cellular level. Moreover, additive ischemic damage caused by thrombosis of the 
hepatic artery, occurring in about 10%, may contribute to the total cellular hypoxygenation. 
Not assessable pathogenic effect of prolonged ischemia in patients after a successful 
thrombectomy and restitution of blood supply may increase the risk for the development of 
ITBL in spite of formally intact vascular status. Unfortunately, current definition of ITBL 
does not allow a clear categorization of this subpopulation. Remarkable similarities of ITBL 
and PSC or biliary pathologies in non-transplant setting resulting from chronic 
inflammation, fibrotic remodeling with a secondary loss of organ function seem to be 
uniform. Although patients transplanted due to PSC may also develop ITBL, no diagnostic 
method can definitively guarantee the differentiation between ITBL and PSC-recurrence. 
Therefore, the relatively high chance of misclassification regarding patient cohorts 
undergoing statistical analysis of etiologic risk factors including epidemiologic aspects may 
explain differences in ITBL-incidence reported in the literature [10, 74]. After the exclusion 
of PSC-patients and managed post-transplant vascular complications the incidence of ITBL 
is supposed to be much lower than 20% [27, 40, 47, 75]. Recent analysis performed in a 
homogenous cohort after the exclusion of patients with prolonged re-arterialization and 
PSC-recurrence, seems to reflect the incidence of ITBL (3.9%) most accurately [1]. Therefore, 
a precise and uniform definition of the disease, awareness of risk factors and potential 
confounders may help to understand the mechanism of ITBL-development, prevent its 
occurrence and progression, select and initiate an adequate treatment. Any progress in the 
understanding of the development and clinical course of post-transplant biliary strictures 
should be welcome at a time of donor organ shortage. 
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